Nchi: Hispania
Lugha: Kiingereza
Chanzo: HMA (Heads of Medicines Agencies)
febantel 0 %, praziquantel 0 %, pyrantel embonate 0 %
Krka d.d.
QP52AC55
Tablet
febantel, combinations
Dogs
2012-06-01
Issued: June 2011 AN: 02514/2008 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dehinel Plus XL Tablets for dogs (Czech Republic, Hungary, Estonia, Latvia, Lithuania, Poland, Romania, Slovenia, Slovakia) Endogard Plus XL Tablets for dogs (United Kingdom, Austria, Belgium, Germany, Denmark, Greece, Ireland, Netherlands, Portugal) Endogard para perros grandes (Spain) Endogard per cani grandi (Italy) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCES: Praziquantel 175 mg Pyrantel embonate 504 mg Febantel 525 mg EXCIPIENTS: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets Oval, biconvex tablets with bevelled edges and scored on both sides. Slightly greenish-yellow. The tablets can be divided into equal halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs (large and extra large size) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed infestations with the following roundworms and tapeworms in adult dogs: Nematodes: Ascarids: _Toxocara canis_, _Toxascaris leonina_ (late immature forms and mature forms) Issued: June 2011 AN: 02514/2008 Page 2 of 6 Hookworms:_ Uncinaria stenocephala_, _Ancylostoma caninum_ (adults) Cestodes: Tapeworms: _Taenia _spp., _Dipylidium caninum_ 4.3 CONTRAINDICATIONS Do not use simultaneously with piperazine compounds. Do not use in animals with a known hypersensitivity to the active substance or to any of excipients. Do no Soma hati kamili